ARGATROBAN Drug Patent Profile
✉ Email this page to a colleague
When do Argatroban patents expire, and when can generic versions of Argatroban launch?
Argatroban is a drug marketed by Amneal Pharms Co, Caplin, Endo Operations, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Pharm Co Ltd, Hospira, Mylan Institutional, Sandoz, Teva Pharms Usa, Cipla, Accord Hlthcare, and Eugia Pharma Speclts. and is included in sixteen NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in ARGATROBAN is argatroban. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the argatroban profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Argatroban
A generic version of ARGATROBAN was approved as argatroban by HIKMA PHARM CO LTD on January 5th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARGATROBAN?
- What are the global sales for ARGATROBAN?
- What is Average Wholesale Price for ARGATROBAN?
Summary for ARGATROBAN
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 34 |
Patent Applications: | 101 |
Drug Prices: | Drug price information for ARGATROBAN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ARGATROBAN |
What excipients (inactive ingredients) are in ARGATROBAN? | ARGATROBAN excipients list |
DailyMed Link: | ARGATROBAN at DailyMed |
Recent Clinical Trials for ARGATROBAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Veralox Therapeutics | Phase 2 |
Veralox Therapeutics | Phase 1 |
Celerion | Phase 1 |
Pharmacology for ARGATROBAN
Drug Class | Anti-coagulant Direct Thrombin Inhibitor |
Mechanism of Action | Thrombin Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ARGATROBAN
Paragraph IV (Patent) Challenges for ARGATROBAN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ARGATROBAN IN SODIUM CHLORIDE | Injection | argatroban | 1 mg/mL, 50 mL vials | 022434 | 1 | 2011-12-16 |
ARGATROBAN | Injection | argatroban | 100 mg/mL, 2.5 mL vials | 020883 | 1 | 2007-09-24 |
US Patents and Regulatory Information for ARGATROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms Co | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 206698-001 | Jan 26, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Eugia Pharma Speclts | ARGATROBAN IN SODIUM CHLORIDE | argatroban | SOLUTION;INTRAVENOUS | 209552-001 | Nov 27, 2018 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma Pharm Co Ltd | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 203049-001 | Jan 5, 2012 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 201811-001 | Mar 23, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | ARGATROBAN IN DEXTROSE | argatroban | SOLUTION;INTRAVENOUS | 201743-001 | May 9, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ARGATROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 020883-001 | Jun 30, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 020883-001 | Jun 30, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ARGATROBAN
See the table below for patents covering ARGATROBAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0823430 | Procédé pour la préparation de N2-arylsulfonyl-L-arginamides (Method for preparing n2-arylsulfonyl-l-argininamides) | ⤷ Sign Up |
European Patent Office | 0301970 | METHOD FOR DISSOLVING ARGININEAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
Spain | 2166937 | ⤷ Sign Up | |
Germany | 69707603 | ⤷ Sign Up | |
Japan | H0576929 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |